EP0587670A4 - Pcp receptor ligands and the use thereof. - Google Patents

Pcp receptor ligands and the use thereof.

Info

Publication number
EP0587670A4
EP0587670A4 EP92911577A EP92911577A EP0587670A4 EP 0587670 A4 EP0587670 A4 EP 0587670A4 EP 92911577 A EP92911577 A EP 92911577A EP 92911577 A EP92911577 A EP 92911577A EP 0587670 A4 EP0587670 A4 EP 0587670A4
Authority
EP
European Patent Office
Prior art keywords
receptor ligands
pcp receptor
pcp
ligands
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92911577A
Other languages
German (de)
French (fr)
Other versions
EP0587670A1 (en
Inventor
Eckard Weber
John F W Keana
Peter Barmettler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon State
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of EP0587670A1 publication Critical patent/EP0587670A1/en
Publication of EP0587670A4 publication Critical patent/EP0587670A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP92911577A 1991-04-29 1992-04-29 Pcp receptor ligands and the use thereof. Withdrawn EP0587670A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69324491A 1991-04-29 1991-04-29
US693244 1991-04-29

Publications (2)

Publication Number Publication Date
EP0587670A1 EP0587670A1 (en) 1994-03-23
EP0587670A4 true EP0587670A4 (en) 1995-02-01

Family

ID=24783901

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92911577A Withdrawn EP0587670A4 (en) 1991-04-29 1992-04-29 Pcp receptor ligands and the use thereof.

Country Status (8)

Country Link
EP (1) EP0587670A4 (en)
JP (1) JPH07500571A (en)
AU (1) AU1910792A (en)
CA (1) CA2109420A1 (en)
IE (1) IE921392A1 (en)
PT (1) PT100431B (en)
WO (1) WO1992019621A1 (en)
ZA (1) ZA923119B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508401A (en) * 1991-02-20 1996-04-16 American Home Products Corporation Substituted dibenzo[a,d]cycloheptene NMDA antagonists
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014813A1 (en) * 1991-02-20 1992-09-03 American Home Products Corporation Neuroprotectant agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597433A (en) * 1968-08-19 1971-08-03 Ayerst Mckenna & Harrison 10,11 - dihydro - 5,10 - (iminomethano)-5h-dibenzo(a,d)cycloheptene and derivatives thereof
US4940789A (en) * 1989-10-10 1990-07-10 American Home Products Corporation 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014813A1 (en) * 1991-02-20 1992-09-03 American Home Products Corporation Neuroprotectant agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9219621A1 *

Also Published As

Publication number Publication date
CA2109420A1 (en) 1992-10-30
IE921392A1 (en) 1992-11-04
AU1910792A (en) 1992-12-21
EP0587670A1 (en) 1994-03-23
WO1992019621A1 (en) 1992-11-12
ZA923119B (en) 1993-01-27
PT100431A (en) 1993-08-31
PT100431B (en) 1999-08-31
JPH07500571A (en) 1995-01-19

Similar Documents

Publication Publication Date Title
EP0714292A4 (en) Sigma receptor ligands and the use thereof
DE69107059D1 (en) Sigma-delta-modulator.
ZA929335B (en) Device.
GR3024174T3 (en) Anchorage.
GR3018318T3 (en) Pharmaceutical agents.
ZA927562B (en) Medicament.
DE69104185D1 (en) Luftreservoir.
DE59204008D1 (en) Trachealstent.
ZA926482B (en) Cyanophenylpyrroles.
DE69106281D1 (en) Phenanthrenderivat.
EP0554456A4 (en) Facsimile-mail device.
EP0613445A4 (en) Dispenser.
DE69102644D1 (en) Demodulationsreferenzsignalquelle.
ZA929724B (en) Ballisitc materials.
DE69205795D1 (en) Mesoprotheseunterlage.
EP0572573A4 (en) Thyroid-derived chondrocyte-stimulating factor.
DE59102290D1 (en) Thermo-fixierstation mit bandtransport.
DE69203865D1 (en) Thermo-transferdrucksystem.
EP0600754A3 (en) Constant pharmaceutical infuser.
DE69204801D1 (en) Hydroxy- oder oxosubstituierte alkylcyclopentene.
ZA929820B (en) Heisswinderschieber.
ZA929331B (en) Quinolylmethoxyphenyl-acetamides.
EP0587670A4 (en) Pcp receptor ligands and the use thereof.
DE59100097D1 (en) Plungerzylinder.
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

RHK1 Main classification (correction)

Ipc: A61K 31/55

A4 Supplementary search report drawn up and despatched

Effective date: 19941216

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

17Q First examination report despatched

Effective date: 19970926

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991103